Your trusted destination for CME, CPD & Medical Education across the Middle East.
The International Symposium on Ophthalmology and Glaucoma Research (ISOGR-26) is a premier hybrid event for professionals to explore the latest research, innovations, and clinical practices. This conference offers a platform for disseminating research, networking with peers, and advancing careers in ophthalmology.
Join the International Symposium on Ophthalmology and Glaucoma Research (ISOGR-26) in Jeddah, Saudi Arabia, or virtually, on October 3-4, 2026. This symposium is designed to bring together the global academic community, researchers, and industry professionals to share groundbreaking insights in ophthalmology and glaucoma. The event features an extensive program of paper and poster presentations, keynote speeches, and workshops, focusing on the latest developments and innovations. Participants will have the opportunity to network with fellow professionals, accelerate their careers, and contribute to discussions that shape the future of eye care, with a special focus on aligning research with global sustainability goals.
Exploring the role of OCT, fundus autofluorescence, and other imaging modalities in the early detection and monitoring of glaucoma.
Discussion on how artificial intelligence algorithms are being used to analyze diagnostic data for improved accuracy and prediction of glaucoma progression.
Investigating new molecular and structural biomarkers for identifying at-risk individuals and tracking disease activity.
Best practices and innovative approaches in designing and implementing robust clinical trials for ophthalmic drugs and devices.
A review of significant findings from recent clinical trials and their impact on current clinical practice and treatment guidelines.
Navigating the regulatory landscape and ethical challenges in conducting ophthalmology research involving human subjects.
Examining sustained-release implants, injectable therapies, and other innovative methods for delivering medication to the eye.
An overview of the progress and potential of gene and cell therapies for treating inherited and acquired retinal diseases.
Updates on the latest pharmacological agents for managing conditions like glaucoma, uveitis, and dry eye disease.
Deep dive into the molecular and cellular mechanisms driving age-related macular degeneration and diabetic retinopathy.
Comparing the outcomes and techniques for managing retinal detachments, macular holes, and other vitreoretinal conditions.
Exploring next-generation treatments for inherited retinal diseases and other complex retinal disorders.
Discussion of femtosecond laser-assisted cataract surgery (FLACS) and other advanced techniques to improve surgical precision and safety.
Evaluating the performance and patient selection criteria for toric, multifocal, and extended depth of focus (EDOF) IOLs.
Strategies for preventing and managing common complications associated with cataract surgery to ensure optimal patient outcomes.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow